Literature DB >> 21948938

Systematic review of national and international guidelines on attention-deficit hyperactivity disorder.

Miguel Seixas1, Margaret Weiss, Ulrich Müller.   

Abstract

During the last few years several clinical guidelines on attention-deficit hyperactivity disorder (ADHD) have been published by national and international medical societies. To systematically review and compare recommendations of selected ADHD guidelines, we performed a systematic search in online guideline databases and PubMed in order to retrieve guideline texts. Guidelines meeting inclusion criteria were reviewed and recommendations on assessment and treatment extracted. The AGREE instrument was used to assess methodological quality. Of the 26 guidelines identified, 13 were selected for further analysis: 11 guidelines deal with ADHD in childhood and adolescence and 5 guidelines cover transitional patients and/or ADHD in adults. The methodological quality of ADHD guidelines is moderate to good. They reflect similarities and differences of healthcare systems. Diagnosis throughout the lifespan is based on a detailed clinical history. There is greater agreement on evidence-based pharmacological treatment than on psychosocial interventions, reflecting the strength of evidence.

Entities:  

Mesh:

Year:  2011        PMID: 21948938     DOI: 10.1177/0269881111412095

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  54 in total

1.  The intraindividual impact of ADHD on the transition of adulthood to old age.

Authors:  Florence Philipp-Wiegmann; Petra Retz-Junginger; Wolfgang Retz; Michael Rösler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-05       Impact factor: 5.270

2.  Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.

Authors:  M Riera; X Castells; A Tobias; R Cunill; L Blanco; D Capellà
Journal:  Psychopharmacology (Berl)       Date:  2017-06-19       Impact factor: 4.530

3.  A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes.

Authors:  Jennifer E Enns; Jason R Randall; Mark Smith; Dan Chateau; Carole Taylor; Marni Brownell; James M Bolton; Elaine Burland; Alan Katz; Laurence Y Katz; Nathan C Nickel
Journal:  Can J Psychiatry       Date:  2017-02-01       Impact factor: 4.356

4.  Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative research.

Authors:  Vanja Sikirica; Emuella Flood; C Noelle Dietrich; Javier Quintero; Val Harpin; Paul Hodgkins; Klaus Skrodzki; Kathleen Beusterien; M Haim Erder
Journal:  Patient       Date:  2015-06       Impact factor: 3.883

5.  Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.

Authors:  Jean Lachaine; Gourab De; Vanja Sikirica; Judy Van Stralen; Paul Hodgkins; Hongbo Yang; Julie Heroux; Leila Ben Amor
Journal:  Can J Psychiatry       Date:  2014-11       Impact factor: 4.356

Review 6.  Current State and Model for Development of Technology-Based Care for Attention Deficit Hyperactivity Disorder.

Authors:  Songpoom Benyakorn; Steven J Riley; Catrina A Calub; Julie B Schweitzer
Journal:  Telemed J E Health       Date:  2016-03-17       Impact factor: 3.536

7.  The effect of methylphenidate intake on brain structure in adults with ADHD in a placebo-controlled randomized trial.

Authors:  Ludger Tebartz van Elst; Simon Maier; Stefan Klöppel; Erika Graf; Carola Killius; Marthe Rump; Esther Sobanski; Dieter Ebert; Mathias Berger; Andreas Warnke; Swantje Matthies; Evgeniy Perlov; Alexandra Philipsen
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

8.  Attention-deficit hyperactivity disorder in patients with premature ejaculation: a pilot study.

Authors:  Hasan Soydan; Ferhat Ates; Cuneyt Adayener; Ilker Akyol; Umit Basar Semiz; Ercan Malkoc; Omer Yilmaz; Cengiz Basoglu; Kadir Vehbi Baykal
Journal:  Int Urol Nephrol       Date:  2012-09-22       Impact factor: 2.370

Review 9.  A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.

Authors:  Tamás Treuer; Susan Shur-Fen Gau; Luis Méndez; William Montgomery; Julie A Monk; Murat Altin; Shenghu Wu; Chaucer C H Lin; Héctor J Dueñas
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-04-06       Impact factor: 2.576

Review 10.  Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.

Authors:  R Cunill; X Castells; A Tobias; D Capellà
Journal:  Psychopharmacology (Berl)       Date:  2015-10-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.